Interventional Oncology | An Emerging Market with Attractive Growth Potential
ID: 1761149
The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%
(firmenpresse) - What the market looks like?
Rising preference for minimally invasive procedures, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research are some of the major factors driving the growth of this market.
According to the new market research report "Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024", published by MarketsandMarkets™.
The Interventional Oncology Market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164
The TARE/SIRT segment accounted for the largest share of the Interventional Oncology Market, by procedure, in 2018
Based on procedure, the Interventional Oncology Market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).
Browse and in-depth TOC on "Interventional Oncology Market"
140 – Tables
33 – Figures
180 – Pages
Global Market Segmentation:
Liver cancer segment to register the highest CAGR in the Interventional Oncology Market, by application, during the forecast period
Based on cancer type, the Interventional Oncology Industry is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer). Growth in this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.
Geographical Analysis:
North America accounted for the largest share of the Interventional Oncology Market in 2018
The Interventional Oncology Industry is segmented into four regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Interventional Oncology Market owing to factors such as the rising incidence of cancer, easy accessibility to interventional oncology, and the high adoption of technological advancements (owing to the significant per capita annual healthcare expenditure by the US government).
Get Your Queries Resolved From Subject Expert | Speak to Our Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=203687164
Key market players:
The major players operating in the Interventional Oncology Industry are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall Interventional Oncology Industry include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands).
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 11.10.2019 - 10:54 Uhr
Sprache: Deutsch
News-ID 1761149
Anzahl Zeichen: 4200
Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Gesundheitswesen - Medizin
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 11.10.2019
Diese Pressemitteilung wurde bisher 385 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Interventional Oncology | An Emerging Market with Attractive Growth Potential"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
Auch du bist Unternehmer - das Unternehmen "Leben" meistern und mehr Zufriedenheit erlangen ...
Wir alle sind in gewisser Weise Unternehmer. Unser Unternehmen ist unser eigenes Leben. Dieses muss man schließlich durch alle Häfen und Klippen steuern und managen, um an eigene Ziele zu kommen. Die einen schaffen dies wie im Schlaf, die anderen müssen hart arbeiten und scheinen nicht weiterzuko
Maronen liefern Vitamine, Mineral- und Ballaststoffe (FOTO) ...
Maronen sind eine Delikatesse, in der sehr viel Gesundes steckt: Ihr weicher essbarer Kern enthält reichlich Mineralstoffe wie Magnesium und Kalium, dazu die Vitamine C, B1, B2 und B6, außerdem Karotin, und auch der Ballaststoffgehalt ist hoch. "Wenn Sie 100 Gramm Maronen essen, haben
Chirurgen und Orthopädie kritisieren geplante Änderung des Notfallsanitätergesetzes: "Ärztlich tätig sein kann und darf nur der Arzt." ...
Stellungnahme der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie (DGOU) zum Entwurf eines Gesetzes zur Änderung des Notfallsanitätergesetzes (Bundesrat, Drucksache 428/19) in Abstimmung mit der Deutschen Gesellschaft für Chirurgie (DGCH), dem Berufsverband Deutscher Chirurgen (BD
Cactus Communications lädt Wissenschaftler zur Teilnahme an globaler Umfrage bezüglich psychischer Gesundheit in der akademischen Welt ein ...
Cactus Communications, ein globales Unternehmen der wissenschaftlich-medizinischen Kommunikation und Technologielösungen, hat eine groß angelegte Umfrage herausgebracht, mit der Einblicke in die Freuden- und Stressauslöser sowie die generelle psychische Gesundheit in der akademischen Welt ge
